Cecilia Gaynor is an expert in the field of Infectious Disease. She attended Indiana University School of Medicine. Indiana University School of Medicine is ranked 45/47 in Research/PrimaryCare. She received awards:"CMS Meaningful Use Stage 1 Certification". Cecilia Gaynor is a published physician as well. She has 3 publications published. The latest was: Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages. She is registered with Medicare and accepts Medicare payments.
NPI NUMBER | 1699732040 | |
NPPES Provider LastName | GAYNOR | |
NPPES Provider FirstName | CECILIA | |
NPPES Provider ZIPCode | 411012873 | |
NPPES Provider State | KY | |
Specialty Description | Infectious Disease | |
Total Claim Count | 1543.0 | |
Distinct Opioid Count | 1.0 | |
Opioid Claim Count | 30.0 | |
Percent Opioid Claims | 1.94 |
National Provider Identifier [NPI] | 1699732040 |
Last Name Of The Provider | GAYNOR |
First Name Of The Provider | CECILIA |
View All |
![]() |
Dr. Patrick G. Villafuerte, MD
![]() |
![]() |
Dr. Mohamed R. Nakeshbandi, MD
![]() |
![]() |
Dr. Fadi Akhrass, MD
![]() ![]() |
![]() |
Dr. Rania N. Rizkallahaboujaoude, MD |